Search filters

List of works by Shai Mulinari

A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding

scientific article published in 2021

An intersectional approach to multilevel analysis of individual heterogeneity (MAIH) and discriminatory accuracy.

scientific article published on March 2017

Appropriate assessment of ethnic differences in adolescent use of psychotropic medication: multilevel analysis of discriminatory accuracy.

scientific article

Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation

scientific article

DRhoGEF2 and diaphanous regulate contractile force during segmental groove morphogenesis in the Drosophila embryo

scientific article published on 20 February 2008

Divergence and convergence of commercial and scientific priorities in drug development: The case of Zelmid, the first SSRI antidepressant

scientific article published on 18 June 2015

Does Maternal Country of Birth Matter for Understanding Offspring's Birthweight? A Multilevel Analysis of Individual Heterogeneity in Sweden

scientific article published on 28 May 2015

Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK

scientific article published on 19 August 2019

Expression and regulation of Spätzle-processing enzyme in Drosophila.

scientific article

Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs

scientific article published on 24 June 2020

Genetics and democracy-what is the issue?

scientific article published on 25 July 2012

Hedgehog, but not Odd skipped, induces segmental grooves in the Drosophila epidermis.

scientific article

Indolent handling of the pharmaceutical industry harms the The Medical Products Agency's credibility

scientific article published on November 14, 2012

Intersectionality and risk for ischemic heart disease in Sweden: Categorical and anti-categorical approaches

scientific article published on 24 January 2017

Measures of discriminatory accuracy and categorizations in public health: a response to Allan Krasnik's editorial

scientific article published on 24 November 2015

Misleading advertising for antidepressants in Sweden: a failure of pharmaceutical industry self-regulation

scientific article

Monoamine theories of depression: historical impact on biomedical research.

scientific article published on January 2012

Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012

scientific article

Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics.

scientific article published on 9 August 2017

Questioning the discriminatory accuracy of broad migrant categories in public health: self-rated health in Sweden

scientific article

Regulating drug information in Europe: a pyrrhic victory for pharmaceutical industry critics? ⬇️

scientific article published on October 24, 2012

Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny

article

Revisiting the pharmaceuticalisation of pandemic influenza using Lukes' framework of power

scientific article published on 10 October 2019

Rho-guanine nucleotide exchange factors during development: Force is nothing without control

scientific article published on July 2010

Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden.

scientific article

Testosterone prescribing in the population-a short social epidemiological analysis in Sweden

scientific article published on 28 July 2015

The specificity triad: notions of disease and therapeutic specificity in biomedical reasoning.

scientific article

The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza

scientific article published on 19 November 2019

Two-Thirds of Survey Respondents in Southern Sweden Used Complementary or Alternative Medicine in 2015

scientific article published on 23 May 2017

Unhealthy marketing of pharmaceutical products: An international public health concern

scientific article published on 25 February 2016

Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews

scientific article

[Not too late for reform]

[Why lie about the causes of depression?]

scientific article published on 01 September 2011

Paulina is supported by:

About Paulina

Help